← Leaderboards
Rocio Gomez-Pastor
University Of Minnesota
$3,847,274
Attributed
$4,029,139
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $871.4K · FY2020–25$1M$750K$500K$250K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,029,139 · 5
By mechanism
R01$2,512,293 · 1
R21$1,206,846 · 3
R03$310,000 · 1
Top collaborators
- Veena Prahlad2 shared
Most similar at University Of Minnesota
Same institution · by research overlap
- Yasushi Nakagawa$2,923,605
- Sundaram Ramakrishnan$4,051,104
- Carli L Poisson$84,603
- Nicholas Rozema$80,016
Others in their field
Other Emerging Leaders on “Neurodegenerative Disorders”
- Hemali Phatnani · New York University School Of Medicine$18,133,462
- Bjorn E Oskarsson · Mayo Clinic Jacksonville$14,441,633
- Afonso C Silva · University Of Pittsburgh At Pittsburgh$12,747,968
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$11,195,609
- James Dale Berry · Brigham And Women'S Hospital$11,004,714
- Frederic Geissmann · Sloan-Kettering Inst Can Research$10,015,052
Research focus
Neurodegenerative DisordersHuntington DiseaseAffectMouse ModelBrainCorpus Striatum StructureGenesNeuronsProteinsCellsHeat Shock Transcription FactorMediatingMotorPathologyImpaired CognitionMutantPreventCell ModelProgramsMolecular ChaperonesBehavioralFunctional DisorderFutureStress
Grant awards (14)
Molecular mechanisms of synaptic dysfunction and cognitive decline in Huntington's disease$564,609
R01 · FY2025 · NS · contact PI
White matter-associated striatal astrocytes and their role in apathy in Huntington's disease$193,750
R21 · FY2025 · NS · contact PI
Cell Signaling Dysregulation in Huntington's Disease$328,891
R01 · FY2024 · NS · contact PI
Assessment of the therapeutic potential of the anticancer agent Silmitasertib in the treatment of memory loss in Frontotemporal dementia$310,000
R03 · FY2024 · AG · contact PI
White matter-associated striatal astrocytes and their role in apathy in Huntington's disease$232,500
R21 · FY2024 · NS · contact PI
Cell Signaling Dysregulation in Huntington's Disease$339,063
R01 · FY2023 · NS · contact PI
Cell Signaling Dysregulation in Huntington's Disease$339,063
R01 · FY2022 · NS · contact PI
Chemical Probes as Allosteric Modulators of CK2 Alpha Prime Targeting Huntington's Disease$189,353
R21 · FY2022 · NS · contact PI
Role of serotonergic-activation of heat shock transcription factor in the regulation of age-related protein misfolding and toxicity in mammalian systems$118,007
R21 · FY2022 · AG
Cell Signaling Dysregulation in Huntington's Disease$337,786
R01 · FY2021 · NS · contact PI
Role of serotonergic-activation of heat shock transcription factor in the regulation of age-related protein misfolding and toxicity in mammalian systems$245,724
R21 · FY2021 · AG
Chemical Probes as Allosteric Modulators of CK2 Alpha Prime Targeting Huntington's Disease$227,512
R21 · FY2021 · NS · contact PI
Cell Signaling Dysregulation in Huntington's Disease$336,875
R01 · FY2020 · NS · contact PI
Cell Signaling Dysregulation in Huntington's Disease$266,006
R01 · FY2020 · NS · contact PI